Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 6,269,500 shares, a growth of 21.8% from the August 15th total of 5,149,100 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is presently 31,347.5 days.
Ono Pharmaceutical Price Performance
OPHLF stock remained flat at $15.50 during midday trading on Monday. Ono Pharmaceutical has a 52 week low of $12.66 and a 52 week high of $19.39. The stock’s fifty day moving average is $14.08 and its two-hundred day moving average is $14.78.
Ono Pharmaceutical (OTCMKTS:OPHLF – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $0.34 EPS for the quarter. The firm had revenue of $754.85 million during the quarter. Ono Pharmaceutical had a return on equity of 14.95% and a net margin of 24.26%. As a group, equities analysts anticipate that Ono Pharmaceutical will post 1.44 earnings per share for the current fiscal year.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Recommended Stories
- Five stocks we like better than Ono Pharmaceutical
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- What is a support level?
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- How to Effectively Use the MarketBeat Ratings Screener
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.